Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Pre-eclampsia remains an important cause of maternal and perinatal mortality. The ability to predict the most severe forms of pre-eclampsia would allow closer surveillance and earlier intervention to improve outcomes. Although no definitive preventative treatment has been found to date, it is likely that prospective treatments would need to start early in pregnancy to alter pathogenesis. Following recent advances in the understanding of the pathogenesis of this complex syndrome, new predictive tests are being evaluated. The most promising models incorporate biochemical and biophysical tests that combine assessments of placentation and maternal disease susceptibility.

More information Original publication

DOI

10.1016/j.bpobgyn.2011.01.002

Type

Journal article

Publication Date

2011-06-01T00:00:00+00:00

Volume

25

Pages

343 - 354

Total pages

11

Keywords

Biomarkers, Blood Pressure, Early Diagnosis, Female, Humans, Pre-Eclampsia, Predictive Value of Tests, Pregnancy, Ultrasonography, Doppler